TP53 and gestational diabetes: In conclusion, our study suggests that increased circ-DNMT1 and p53 in PE and GDM placentas alters the biological function of trophoblast cells in vitro by activating JAK/STAT signaling pathways, and provides a promising therapeutic strategy for PE and GDM.